Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp PROF


Primary Symbol: T.PRN

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Profound Medical Announces Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire March 3, 2020

Profound Medical Participate in March Investor Healthcare Conferences

GlobeNewswire February 26, 2020

Profound Medical to Release Fourth Quarter and Full Year 2019 Financial Results on March 3 - Conference Call to Follow

GlobeNewswire February 12, 2020

Profound Medical Retires Bank Debt Ahead of Schedule

GlobeNewswire February 4, 2020

Profound Medical Announces Closing of Offering

GlobeNewswire January 27, 2020

IIROC Trade Resumption - PRN

Canada NewsWire January 22, 2020

IIROC Trading Halt - PRN

Canada NewsWire January 22, 2020

Profound Medical Announces Pricing of Offering of Common Shares

GlobeNewswire January 22, 2020

Profound Medical Announces Proposed Offering of Common Shares

GlobeNewswire January 21, 2020

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenues & Provides TULSA-PRO® U.S. Commercialization Update

GlobeNewswire January 10, 2020

Profound Medical and RadNet Sign the First-Ever U.S. Multi-Center Commercial Agreement for TULSA-PRO®

GlobeNewswire January 10, 2020

Profound Medical to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

GlobeNewswire December 3, 2019

Profound Medical Announces Health Canada Approval of TULSA-PRO®

GlobeNewswire November 25, 2019

Profound Medical Announces Third Quarter 2019 Financial Results

GlobeNewswire November 7, 2019

Profound Medical Corp. Opens the Market

Canada NewsWire October 31, 2019

Profound to Participate in November Investor Healthcare Conferences

GlobeNewswire October 31, 2019

Profound Medical Announces Nasdaq Listing

GlobeNewswire October 28, 2019

Profound Medical to Release Third Quarter 2019 Financial Results on November 7 - Conference Call to Follow

GlobeNewswire October 24, 2019

Profound Medical Corp. Announces Share Consolidation in Connection With Proposed Nasdaq Listing

GlobeNewswire October 11, 2019

Profound Medical Proposes New MJDS Registration for its Proposed U.S. Listing

GlobeNewswire September 23, 2019